Report Detail

Medical Devices & Consumables Global Human Serum and Plasma Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4660399
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Human Serum and Plasma market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
This report is a detailed and comprehensive analysis for global Human Serum and Plasma market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Serum and Plasma market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Serum and Plasma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Serum and Plasma market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Serum and Plasma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fresh Human Serum and Plasma
Frozen Human Serum and Plasma
Market segment by Application
In Vitro Diagnostics
Vaccines and Antibodies
Cell Culture
Clinical Research
Others
Major players covered
Akron
Baxter
Cytiva
Merck Millipore
Monobind
SeraCare
TCS Biosciences Ltd
Thermo Fisher
Trina Bioreactives
Zen-Bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Serum and Plasma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Serum and Plasma, with price, sales quantity, revenue, and global market share of Human Serum and Plasma from 2020 to 2025.
Chapter 3, the Human Serum and Plasma competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Serum and Plasma breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Serum and Plasma market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Serum and Plasma.
Chapter 14 and 15, to describe Human Serum and Plasma sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Serum and Plasma Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Fresh Human Serum and Plasma
    • 1.3.3 Frozen Human Serum and Plasma
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Serum and Plasma Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 In Vitro Diagnostics
    • 1.4.3 Vaccines and Antibodies
    • 1.4.4 Cell Culture
    • 1.4.5 Clinical Research
    • 1.4.6 Others
  • 1.5 Global Human Serum and Plasma Market Size & Forecast
    • 1.5.1 Global Human Serum and Plasma Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Human Serum and Plasma Sales Quantity (2020-2031)
    • 1.5.3 Global Human Serum and Plasma Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Akron
    • 2.1.1 Akron Details
    • 2.1.2 Akron Major Business
    • 2.1.3 Akron Human Serum and Plasma Product and Services
    • 2.1.4 Akron Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Akron Recent Developments/Updates
  • 2.2 Baxter
    • 2.2.1 Baxter Details
    • 2.2.2 Baxter Major Business
    • 2.2.3 Baxter Human Serum and Plasma Product and Services
    • 2.2.4 Baxter Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Baxter Recent Developments/Updates
  • 2.3 Cytiva
    • 2.3.1 Cytiva Details
    • 2.3.2 Cytiva Major Business
    • 2.3.3 Cytiva Human Serum and Plasma Product and Services
    • 2.3.4 Cytiva Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Cytiva Recent Developments/Updates
  • 2.4 Merck Millipore
    • 2.4.1 Merck Millipore Details
    • 2.4.2 Merck Millipore Major Business
    • 2.4.3 Merck Millipore Human Serum and Plasma Product and Services
    • 2.4.4 Merck Millipore Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Merck Millipore Recent Developments/Updates
  • 2.5 Monobind
    • 2.5.1 Monobind Details
    • 2.5.2 Monobind Major Business
    • 2.5.3 Monobind Human Serum and Plasma Product and Services
    • 2.5.4 Monobind Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Monobind Recent Developments/Updates
  • 2.6 SeraCare
    • 2.6.1 SeraCare Details
    • 2.6.2 SeraCare Major Business
    • 2.6.3 SeraCare Human Serum and Plasma Product and Services
    • 2.6.4 SeraCare Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 SeraCare Recent Developments/Updates
  • 2.7 TCS Biosciences Ltd
    • 2.7.1 TCS Biosciences Ltd Details
    • 2.7.2 TCS Biosciences Ltd Major Business
    • 2.7.3 TCS Biosciences Ltd Human Serum and Plasma Product and Services
    • 2.7.4 TCS Biosciences Ltd Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 TCS Biosciences Ltd Recent Developments/Updates
  • 2.8 Thermo Fisher
    • 2.8.1 Thermo Fisher Details
    • 2.8.2 Thermo Fisher Major Business
    • 2.8.3 Thermo Fisher Human Serum and Plasma Product and Services
    • 2.8.4 Thermo Fisher Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Thermo Fisher Recent Developments/Updates
  • 2.9 Trina Bioreactives
    • 2.9.1 Trina Bioreactives Details
    • 2.9.2 Trina Bioreactives Major Business
    • 2.9.3 Trina Bioreactives Human Serum and Plasma Product and Services
    • 2.9.4 Trina Bioreactives Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Trina Bioreactives Recent Developments/Updates
  • 2.10 Zen-Bio
    • 2.10.1 Zen-Bio Details
    • 2.10.2 Zen-Bio Major Business
    • 2.10.3 Zen-Bio Human Serum and Plasma Product and Services
    • 2.10.4 Zen-Bio Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Zen-Bio Recent Developments/Updates

3 Competitive Environment: Human Serum and Plasma by Manufacturer

  • 3.1 Global Human Serum and Plasma Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Human Serum and Plasma Revenue by Manufacturer (2020-2025)
  • 3.3 Global Human Serum and Plasma Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Human Serum and Plasma by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Human Serum and Plasma Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Human Serum and Plasma Manufacturer Market Share in 2024
  • 3.5 Human Serum and Plasma Market: Overall Company Footprint Analysis
    • 3.5.1 Human Serum and Plasma Market: Region Footprint
    • 3.5.2 Human Serum and Plasma Market: Company Product Type Footprint
    • 3.5.3 Human Serum and Plasma Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Serum and Plasma Market Size by Region
    • 4.1.1 Global Human Serum and Plasma Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Human Serum and Plasma Consumption Value by Region (2020-2031)
    • 4.1.3 Global Human Serum and Plasma Average Price by Region (2020-2031)
  • 4.2 North America Human Serum and Plasma Consumption Value (2020-2031)
  • 4.3 Europe Human Serum and Plasma Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Human Serum and Plasma Consumption Value (2020-2031)
  • 4.5 South America Human Serum and Plasma Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Human Serum and Plasma Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Human Serum and Plasma Sales Quantity by Type (2020-2031)
  • 5.2 Global Human Serum and Plasma Consumption Value by Type (2020-2031)
  • 5.3 Global Human Serum and Plasma Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Human Serum and Plasma Sales Quantity by Application (2020-2031)
  • 6.2 Global Human Serum and Plasma Consumption Value by Application (2020-2031)
  • 6.3 Global Human Serum and Plasma Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Human Serum and Plasma Sales Quantity by Type (2020-2031)
  • 7.2 North America Human Serum and Plasma Sales Quantity by Application (2020-2031)
  • 7.3 North America Human Serum and Plasma Market Size by Country
    • 7.3.1 North America Human Serum and Plasma Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Human Serum and Plasma Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Human Serum and Plasma Sales Quantity by Type (2020-2031)
  • 8.2 Europe Human Serum and Plasma Sales Quantity by Application (2020-2031)
  • 8.3 Europe Human Serum and Plasma Market Size by Country
    • 8.3.1 Europe Human Serum and Plasma Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Human Serum and Plasma Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Human Serum and Plasma Market Size by Region
    • 9.3.1 Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Human Serum and Plasma Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Human Serum and Plasma Sales Quantity by Type (2020-2031)
  • 10.2 South America Human Serum and Plasma Sales Quantity by Application (2020-2031)
  • 10.3 South America Human Serum and Plasma Market Size by Country
    • 10.3.1 South America Human Serum and Plasma Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Human Serum and Plasma Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Human Serum and Plasma Market Size by Country
    • 11.3.1 Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Human Serum and Plasma Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Human Serum and Plasma Market Drivers
  • 12.2 Human Serum and Plasma Market Restraints
  • 12.3 Human Serum and Plasma Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Serum and Plasma and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Serum and Plasma
  • 13.3 Human Serum and Plasma Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Serum and Plasma Typical Distributors
  • 14.3 Human Serum and Plasma Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Serum and Plasma. Industry analysis & Market Report on Human Serum and Plasma is a syndicated market report, published as Global Human Serum and Plasma Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Human Serum and Plasma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report